Medi Caps Current Share Price | Medi Caps Stock Screener
MEDICAPQ
Pharmaceuticals
Medi Caps Current Stock Price Today
Live Share Price NSE
₹25.05
▼
-0.21 (-0.83%)
Live Share Price BSE
₹25.11
▼
-0.53 (-2.07%)
As of August 18, 2026, the live Medi Caps share price (NSE: MEDICAPQ) is ₹25.05 on NSE and ₹25.11 on BSE, down 0.83% from the previous close, with shares trading between ₹20.33 and ₹27.68 in today's trading session, and a 52-week range of ₹25.05–₹25.26.
Analyse MEDICAPQ price trends and track historical price performance.
Use the Medi Caps stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Medi Caps Market Cap
₹34.27 Cr.
MEDICAPQ P/E Ratio (TTM)
-18.82
Medi Caps P/B Ratio
0.30
EPS (TTM)
₹-2.44
Dividend Yield
-
Debt to Equity
-
MEDICAPQ 52 Week High
₹25.26
Medi Caps 52 Week Low
₹25.05
Operating Margin
-70.00%
Profit Margin
-66.67%
MEDICAPQ Revenue (TTM)
₹3.00
EBITDA
₹-2.00
Net Income
₹-2.00
Total Assets
₹116.00
Total Equity
₹112.00
Medi Caps Current Share Price Chart
Track the current Medi Caps share price and stock price with an interactive chart. Analyse MEDICAPQ price trends, trading volume, historical performance, and volatility across different timeframes — the complete Medi Caps stock quote in one place.
Medi Caps Company Profile - Fundamental Screener
Screen Medi Caps company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for MEDICAPQ shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE442D01010
Medi Caps Balance Sheet Screener
Screen MEDICAPQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 116 | 125 | 127 | 126 | 130 | 115 | 95 | 107 | 101 | 97 |
| Current Assets | 47 | 53 | 60 | 60 | 67 | 53 | 33 | 42 | 37 | 33 |
| Fixed Assets | 27 | 57 | 59 | 59 | 59 | 58 | 57 | 60 | 61 | 62 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 112 | 121 | 121 | 119 | 116 | 105 | 91 | 96 | 90 | 89 |
| Share Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves & Surplus | 99 | 109 | 109 | 106 | 104 | 92 | 79 | 83 | 78 | 77 |
Medi Caps Income Statement Screener - Profit & Revenue Analysis
Screen Medi Caps income statement and profit fundamentals.
Analyze MEDICAPQ quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Medi Caps share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 9 | 5 | 4 | 3 | 9 | 8 | 6 | 9 | 4 | 10 | 6 | 6 | 7 | 18 |
| Expenses | 5 | 6 | 5 | 5 | 6 | 7 | 8 | 7 | 8 | 6 | 10 | 7 | 6 | 6 | 17 |
| EBITDA | -2 | 4 | 0 | -1 | -3 | 2 | -1 | 0 | 1 | -2 | 1 | -1 | 1 | 1 | 1 |
| Operating Profit % | -70.00% | -61.00% | -25.00% | -145.00% | -126.00% | -4.00% | -13.00% | -5.00% | 5.00% | -45.00% | 4.00% | -14.00% | 8.00% | 8.00% | -3.00% |
| Depreciation | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -2 | 3 | -1 | -2 | -4 | 2 | -1 | -1 | 0 | -2 | 1 | -1 | 0 | 0 | 2 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Net Profit | -2 | 3 | -1 | -2 | -4 | 2 | -1 | -1 | 0 | -2 | 0 | -1 | 0 | 0 | 2 |
| EPS | -1.79 | 2.44 | -0.61 | -1.46 | -2.80 | 1.38 | -0.86 | -0.45 | 0.25 | -1.64 | -0.31 | -0.89 | 0.09 | -0.13 | 1.20 |
Medi Caps Cash Flow Screener - Liquidity Fundamentals
Screen MEDICAPQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 5 | 7 | -6 | 7 | 15 | 5 | 6 | 4 | 4 | 3 |
| Investing Activities | -5 | -8 | -3 | -4 | -10 | -6 | -6 | -4 | 3 | -2 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6 | -1 |
| Net Cash Flow | 0 | -1 | -9 | 3 | 6 | -1 | 0 | 0 | 1 | 0 |
Medi Caps Shareholding Pattern Screener
See Medi Caps shareholding pattern with promoter, FII, and DII holdings.
Check Medi Caps promoter holding and ownership changes for MEDICAPQ on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 51.44% | 51.36% | 50.76% | 50.77% | 50.77% | 50.77% | 50.62% | 50.43% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.02% | 0.02% | 0.02% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 43.76% | 43.93% | 44.43% | 44.31% | 44.34% | 44.57% | 44.37% | 44.07% |
| Other Holding | 4.78% | 4.68% | 4.79% | 4.89% | 4.86% | 4.63% | 4.99% | 5.48% |
| Shareholder Count | 10,209 | 10,349 | 10,493 | 10,692 | 10,851 | 11,033 | 11,176 | 11,255 |
Medi Caps Share Dividend Screener - Share Yield Analysis
Check Medi Caps dividend history with payout and yield data.
View Medi Caps dividend details including ex-dates and amounts for MEDICAPQ stock.
Medi Caps Stock Index Membership
See which indices include Medi Caps stock.
Check MEDICAPQ index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Medi Caps Market Events Screener - Corporate Actions
Get Medi Caps corporate actions including splits, bonuses, and buybacks.
Check Medi Caps stock events that may affect MEDICAPQ share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-22 | 2026-09-22 | Annual General Meeting | NA | 1.27% |
| 2026-08-06 | 2026-08-06 | Quarterly Result Announcement | NA | 2.26% |
| 2026-05-21 | 2026-05-21 | Quarterly Result Announcement | NA | -6.05% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | -3.93% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 0.19% |
| 2025-09-18 | 2025-09-18 | Annual General Meeting | NA | -10.05% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | 2.40% |
| 2025-05-21 | 2025-05-21 | Quarterly Result Announcement | NA | 0.87% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -5.40% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -6.24% |
| 2024-09-26 | 2024-09-26 | Annual General Meeting | NA | 4.08% |
Medi Caps Competitors Screener - Peer Comparison
Screen MEDICAPQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 463,072 | 38.47 | 61,674 | 12.69% | 11,565 | 47.09 |
| Divis Laboratories | 225,038 | 77.15 | 11,067 | 13.95% | 2,568 | 71.85 |
| Torrent Pharmaceuticals | 183,832 | 86.03 | 13,886 | 20.34% | 2,138 | 45.42 |
| Cipla | 117,138 | 35.17 | 29,045 | 2.24% | 3,870 | 50.74 |
| Zydus Life Science | 114,228 | 25.48 | 27,658 | 17.64% | 5,026 | 50.68 |
| Lupin | 102,191 | 18.62 | 29,039 | 26.75% | 5,356 | 30.04 |
| Dr Reddys Laboratories | 100,160 | 31.62 | 35,059 | 3.90% | 4,158 | 49.18 |
| Mankind Pharma | 100,160 | 48.30 | 14,636 | 14.85% | 1,938 | 43.34 |
| Laurus Labs | 96,489 | 91.23 | 6,868 | 22.01% | 890 | 61.64 |
| Aurobindo Pharma | 93,332 | 25.93 | 34,145 | 5.56% | 3,503 | 55.68 |
Medi Caps Company Announcements - News Screener
Screen MEDICAPQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-11 | Disclosure Under 30(5) Of SEBI (LODR) Regulation 2015 | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-09 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-09 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-09 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-09 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-09 | Submission Of Unaudited Standalone And Consolidated Financial Result For The Quarter Ended 30.06.2026. | - |
| 2026-08-09 | Board Meeting Outcome for Outcome Of Board Meeting Held On 06.08.2026 | - |
| 2026-07-30 | Announcement under Regulation 30 (LODR)-Resignation of Chairman | - |
| 2026-07-30 | Announcement under Regulation 30 (LODR)-Resignation of Director | - |
| 2026-07-30 | Board Meeting Intimation for (Serial No. 02/2026-27) Of The Company Scheduled To Be Held On Thursday 06Th Day Of August 2026 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-07-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-25 | Closure of Trading Window | - |
| 2026-06-08 | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | - |
| 2026-05-23 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-23 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-21 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-21 | Submission Of Audited Standalone And Consolidated Financial Results For The Fourth Quarter As Well As Financial Year Ended 31St March 2026 Along With The Auditors Report Thereon Statement Of Assets And Liabilities And Cash Flow Statement. | - |
| 2026-05-21 | Board Meeting Outcome for OUTCOME OF THE BOARD MEETING HELD ON 21.05.2026 PURSUANT TO REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS 2015. | - |
| 2026-05-14 | Board Meeting Intimation for Meeting Of Board Of Directors (Serial No. 01/2026-27) Of The Company Scheduled To Be Held On Thursday 21St Day Of May 2026 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |